Review

Hypoxia-inducible factor-1 (HIF-1) in the molecular mechanisms of liver fibrosis: research progress on its role and therapeutic strategies.

Cai-Yun Zhou Li Wang

Aug 2026 · Journal of Applied Genetics · 0 citations · 103 references

Medicine

TL;DR

The molecular regulatory network of HIF-1 in liver fibrosis is reviewed to provide theoretical support and identify future research directions for targeted therapy of liver fibrosis, thereby facilitating the clinical translation of relevant treatment approaches.

DOI PubMed Semantic Scholar

View source

Similar papers

Review Open access Aug 2026

Understanding the role of hypoxia inducible factors in liver fibrosis and future therapeutic applications

An overview of the current evidence on the role of HIF-1α in liver fibrosis and its connection between the major profibrotic pathways is provided and information on the new therapeutic approaches targeting hypoxia signaling is provided.

Yasha Taimuri, Riaz Ahmad · iLiver · 0 citations

Review Open access Aug 2026

Contribution of p38 MAPK in liver fibrosis: An overview of mechanisms, signaling pathways, and therapeutic targets (Review)

While p38 MAPK represents a promising therapeutic target for liver fibrosis, future research should focus on developing isoform-specific inhibitors, understanding context-dependent signaling outcomes, and designing combination therapies to enhance efficacy and minimize off-target effects.

Xueqin Yang, Hua-Rong Li, Hao-Sen Ye et al. · International Journal of Mol... · 0 citations

Review Open access Aug 2026

The NRF2 signaling pathway in hepatocellular carcinoma: dual roles, epigenetic reprogramming, and therapeutic opportunities in metabolic vulnerability

NRF2-related metabolic pathways and redox defense systems exhibit potential metabolically targetable vulnerabilities, providing a theoretical basis for combined induction of ferrocytosis and metabolic intervention in HCC.

Yue Wang, Lingwei Gao, Hao-Bo Yang et al. · Frontiers in Oncology · 0 citations

Review Open access Sep 2026

Regulatory Mechanisms Within Multicellular Signaling Networks in Liver Ischemia–Reperfusion Injury: A Systematic Review Focusing on Cell‐Type‐Specific Interactions

This article systematically reviews the mutual regulatory mechanisms of various liver cells during hepatic ischemia–reperfusion, focusing on intercellular signal communication and pathophysiological changes, and integrates recent advancements to evaluate their potential applications in disease prevention and treatment.

Lei Sun, Die Hu, Xue-Kun Xing · The FASEB Journal · 0 citations

Review Open access Aug 2026

The role of HIF-1α in myocardial ischemia protection mechanisms and multi-target rational regulation strategies for natural products

Current insights into the regulatory role of HIF-1α in myocardial ischaemic injury are summarized and the therapeutic potential of NPs in modulating this pathway is highlighted, providing a foundation for novel anti-ischaemic drug development.

Sisi He, Yuyao Wang, Qi Shi et al. · Frontiers in Pharmacology · 0 citations

Open access Sep 2026

HIF-1α-ASS1 axis drives reprogramming of arginine metabolism controls hepatic stellate cell activation in hepatic fibrosis.

ABRL8301 acts as a pharmacologic inducer of ASS1 and arginine biosynthesis, inhibiting EMT and fibrotic progression while enhancing anticancer therapy and support ABRL8301 as a promising antifibrotic and tumor-sensitizing agent in hepatic fibrosis.

Seungeun Lee, Yeonhwa Song, Sanghwa Kim et al. · Phytomedicine · 0 citations